WallStreetZenWallStreetZen

NASDAQ: SMMT
Summit Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Summit Therapeutics earnings were -$921.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest SMMT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$231.8M, down 59% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SMMT reported annual earnings of -$221.3M, with -64% growth.

SMMT earnings history

Current Revenue
$0.0
Current Earnings
-$921.6M
Current Profit Margin
0%

SMMT Return on Equity

Current Company
-311.2%
Current Industry
-32.6%
Current Market
38.3%
SMMT's Return on Equity (-311.2%)... subscribe to Premium to read more.
High Return on Equity Performance

SMMT undefined

Current Company
-262.4%
Current Industry
-22.1%
SMMT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SMMT announces earnings.

SMMT undefined

Current Company
-463.89%
Current Industry
-32.1%
SMMT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SMMT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SMMT-$912.81M-$921.62MN/A-$0.01
ROIV-$432.28M-$490.63MN/A-$0.70
ASND-$194.68M-$388.26MN/A-$6.65
BBIO-$664.27M-$797.12MN/A-$4.20
IONS-$147.39M-$256.34MN/A-$1.61
View Top Biotech Stocks

Summit Therapeutics Earnings Reports & History FAQ

What were Summit Therapeutics's earnings last quarter?

On SMMT's earnings call on Invalid Date, Summit Therapeutics (NASDAQ: SMMT) reported Q3 2025 earnings per share (EPS) of -$0.00, up 200% year over year. Total SMMT earnings for the quarter were -$231.79 million. In the same quarter last year, Summit Therapeutics's earnings per share (EPS) was -$0.00.

If you're new to stock investing, here's how to buy Summit Therapeutics stock.

Is Summit Therapeutics profitable or losing money?

As of the last Summit Therapeutics earnings report, Summit Therapeutics is currently losing money. Summit Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$921.62 million, a 368.59% increase year over year.

What was SMMT's earnings growth in the past year?

As of Summit Therapeutics's earnings date in Invalid Date, Summit Therapeutics's earnings has grown year over year. SMMT earnings in the past year totalled -$921.62 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.